Compare ASIC & ATEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ASIC | ATEC |
|---|---|---|
| Founded | 2018 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2025 | 2006 |
| Metric | ASIC | ATEC |
|---|---|---|
| Price | $25.84 | $9.45 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 11 |
| Target Price | ★ $26.75 | $22.00 |
| AVG Volume (30 Days) | 50.9K | ★ 2.2M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 23.44 | 15.04 |
| EPS | ★ 1.18 | N/A |
| Revenue | ★ $424,339,000.00 | $101,739,000.00 |
| Revenue This Year | $34.21 | $18.97 |
| Revenue Next Year | $34.65 | $16.70 |
| P/E Ratio | $21.43 | ★ N/A |
| Revenue Growth | ★ 23.41 | N/A |
| 52 Week Low | $16.35 | $6.82 |
| 52 Week High | $26.00 | $23.29 |
| Indicator | ASIC | ATEC |
|---|---|---|
| Relative Strength Index (RSI) | 62.76 | 49.52 |
| Support Level | $18.75 | $8.90 |
| Resistance Level | N/A | $9.75 |
| Average True Range (ATR) | 0.95 | 0.44 |
| MACD | 0.04 | -0.05 |
| Stochastic Oscillator | 94.36 | 28.19 |
Ategrity Specialty Insurance Co Holdings is a specialty property and casualty insurance holding company focused on the excess and surplus market for small to medium-sized businesses (SMBs) across the United States. Operating through its subsidiaries, the company underwrites small and medium-sized commercial risks across selected industry verticals, including Retail, Real Estate, Hospitality, and Construction. Its operating model uses a technology-driven method to standardize, simplify, and, where appropriate, automate these transactions. The group distributes its products through licensed surplus lines brokers and wholesale agents.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.